Purple Launches Global Partner Webinar Series to Address Rising WiFi Demand and the “Beyond Connectivity” Opportunity
Publishing Insiders Launch Next Chapter AI, Offering Ethical AI Strategy and Training to the Book Publishing Industry
AI Producer Launches AI Producer in Teams as a Managed Application for Enterprises
Nominal Accelerates Naval Aviation Testing and Validation for Future Collaborative Combat Aircraft
0G and Stanford Blockchain Veterans Launch $20M Apollo AI Accelerator
Tecentriq significantly improved overall survival in people with high PD-L1 expression, compared with chemotherapy in…
Strong cash and cash equivalents position at March 31, 2021 of CHF25.2M ($26.7M) Completed $11.5M…
Saint-Herblain (France), May 5, 2021 – Valneva SE (the “Company”), a specialty vaccine company focused…
ROCKVILLE, Md., May 04, 2021 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical…
On track to refile Libervant™ (diazepam) Buccal Film New Drug Application (NDA) by end of…
BOTHELL, Wash., May 04, 2021 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (Nasdaq: COCP), (“Cocrystal” or the “Company”), a…
First-of-its-kind software predicts likelihood of off-target safety issues that could impede clinical progress PRINCETON, N.J.,…
Vertically-integrated cannabis leader finishes quarter with multiple post-merger successes and strong position for future expansion…
OXFORD, United Kingdom, May 04, 2021 (GLOBE NEWSWIRE) — Vaccitech plc (NASDAQ: VACC), a clinical-stage…
Transformative, leading allogeneic NKT cell platform technology expands Athenex’s cell therapy development capability Platform has…
New Drug Application (NDA) submission for topical roflumilast cream as a potential treatment for plaque…
SAN CARLOS, Calif., May 04, 2021 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a…
Multiple pre-clinical studies indicate that Lixte’s lead clinical drug candidate LB-100 enhances the effectiveness of…
ERYTECH Provides Business Update and Reports Financial Results for the First Quarter of 2021 Conference…
SEATTLE, May 04, 2021 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company…
REDWOOD CITY, Calif., May 04, 2021 (GLOBE NEWSWIRE) — Seer, Inc., (Nasdaq: SEER), a life…
COPENHAGEN, Denmark, May 04, 2021 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical…
Novel candidate in development aims to be first approved non-vaccine therapeutic for Lyme disease prevention…
DEER PARK, Ill., May 04, 2021 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc (Nasdaq: ETON), an…
Prescription Growth Reflects Increasing Demand for Twirla Base of Prescribers Continues to Grow in First…